zepbound tirzepatide side effects Mounjaro vs Zepbound: Know the Difference, Benefits & Zepbound Side Effects: Comprehensive Guide
Description
Tirzepatide is a dual GIP/GLP-1 receptor agonist administered weekly by subcutaneous injection for type 2 diabetes management
It targets three receptors (GIP + GLP-1 + glucagon), giving extremely powerful appetite control and fat-burning
Standard titration schedule The protocol used in phase 2 and phase 3 clinical trials follows this pattern: Each dose step lasts four weeks
TRIUMPH-3 (expected later 2026) TRIUMPH-3 enrolls adults with obesity and established cardiovascular disease not sleep apnea, as some sources have incorrectly described it
This drug also changes the appetite of individuals who take this drug by slowing down the process of emptying the stomach
